Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells

Nephrology Dialysis Transplantation

Volumn 24, Issue 6, 2009, Pages 1766-1773

  Gava, Elisandra ^a   Samad Zadeh, Arman ^a   Zimpelmann, Joseph ^a   Bahramifarid, Nasim ^a   Kitten, Gregory T ^b   Santos, Robson A ^c   Touyz, Rhian M ^a   Burns, Kevin D ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Department of Morphology ^*

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiotensin; Diabetic nephropathy; Proximal tubule; Receptor Mas; Renin angiotensin system

Indexed keywords

ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; ARSENOSOBENZENE; COLLAGEN TYPE 4; FIBRONECTIN; GLUCOSE; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE PHOSPHATASE SHP 1; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANGIOTENSIN I; ANIMALS; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; ENZYME ACTIVATION; FIBRONECTINS; GLUCOSE; HUMANS; KIDNEY TUBULES, PROXIMAL; LLC-PK1 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTEIN TYROSINE PHOSPHATASES; SIGNAL TRANSDUCTION; SWINE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67651121856     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn736     Document Type: Article

References (39)

1. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamic to molecular pathology. Eur J Clin Invest 2004; 34: 785-796
2. Braam B, Mitchell KD, Fox J et al. Proximal tubular secretion of angiotensin II in rats. Am J Physiol Renal Physiol 1993; 264: F891-F898
3. Seikaly MG, Arant BS Jr, Seney FD Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990; 86: 1352-1357
4. Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 2005; 67: 799-812
5. Donoghue M, Hsieh F, Baronas E et al. A novel angiotensin- converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1-E9
6. Tipnis SR, Hooper NM, Hyde R et al. A human homolog of angiotensin-converting enzyme. cloning and functional expression as a captopril-insensitive carboxypeptidase. JBiolChem 2000; 275: 33238-33243
7. Brosnihan KB, Neves LAA, Joyner J et al. Enhanced renal immuno-cytochemical expression of Ang-(1-7) and ACE2 during pregnancy. Hypertension 2003; 42: 749-753
8. Li N, Zimpelmann J, Cheng K et al. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 2005; 288: F353-F362
9. Shaltout HA, Westwood BM, Averill DB et al. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 2007; 292: F82-F91
10. Pendergrass KD, Averill DB, Ferrario CM et al. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2 Lewis rat. Am J Physiol Renal Physiol 2006; 290: F1497-F1506
11. Benter IF, Yousif MH, Cojocel C et al. Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Circ Physiol 2007; 292: H6666-H6672
12. Ferreira A, Pinheiro SVB, Castro CH et al. Renal function in transgenic rats expressing an angiotensin-(1-7)-producing fusion protein. Regul Pept 2006; 137: 128-133
13. Handa RK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol Renal Physiol 1996; 270: F141-F147
14. Ren Y, Garvin JL, Carretero OA. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 2002; 39: 799-802
15. Santos RA, Simoes Silva AC, Maric C et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor mas. Proc Natl Acad Sci USA 2003; 100: 8258-8263
16. Su Z, Zimpelmann J, Burns KD. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006; 69: 2212-2218
17. Fujita H, Omori S, Ishikura K et al. ERK and p38 mediate high glucose-induced hypertrophy and TGF-β expression in renal tubular cells. Am J Physiol Renal Physiol 2004; 286: F120-F126
18. Amiri F, Venema VJ, Wang X et al. Hyperglycemia enhances angiotensin II-induced Janus-activated kinase/STAT signaling in vascular smooth muscle cells. JBiolChem 1999; 274: 32382-32386
19. Cui T, Nakagami H, Iwai M et al. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. Cardiovasc Res 2001; 49: 863-871
20. Matsubara H, Shibasaki Y, Okigaki M et al. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor. Biochem Biophys Res Commun 2001; 282: 1085-1091
21. Garcia-Morales P, Minami Y, Luong E et al. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Biochemistry 1990; 87: 9255-9259
22. Alenina N, Xu P, Rentzsch B et al. Genetically altered models for Mas and angiotensin-(1-7). Exp Physiol 2008; 93: 528-537
23. Zohn IE, Symons M, Chrzanowska-Wodnicka M et al. Mas oncogene signaling and transformation require the small GTP-binding protein Rac. Mol Cell Biol 1998; 18: 1225-1235
24. Giani JF, Gironacci MM, Munoz MC et al. Angiotensin-(1-7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and mas receptors. Am J Physiol Heart Circ Physiol 2007; 293: H1154-H1163
25. Sampaio WO, Souza dos Santos RA, Faria-Silva R et al. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007; 49: 185-192
26. Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 2005; 289: H1560-H1566
27. Sampaio WO, Henrique de Castro C, Santos RA et al. Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 2007; 50: 1093-1098
28. Andreatta-van Leyen S, Romero MF, Khosla MC et al. Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney Int 1993; 44: 932-936
29. +-ATPase activity via a A779-sensitive receptor. Regul Pept 2002; 103: 17-22
30. +-ATPase activity by Ang-(1-7). Exp Physiol 2008; 93: 639-647
31. 2 receptor orthologues in closely related species. Kidney Int 2005; 67: 1731-1738
32. Hannken T, Schroeder R, Stahl RAK et al. Atrial natriuretic peptide attenuates ANG II-induced hypertrophy of renal tubular cells. Am J Physiol Renal Physiology 2001; 281: F81-F90
33. Teng C-H, Huang W-N, Meng T.-C. Several dual specificity phos-phatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress. JBiolChem 2007; 282: 28395-28407
34. Shen SH, Bastien L, Posner BI et al. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 1991; 352: 736-739
35. Morrissey K, Steadman R, Williams JD et al. Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent. Kidney Int 1999; 55: 160-167
36. Phillips AO, Steadman R, Morrissey K et al. Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Kidney Int 1997; 52: 973-984
37. Ziyadeh FN, Snipes ER, Watanabe M et al. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 1990; 28: F704-F714
38. Maia LG, Ramos MC, Fernandes L et al. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats. J Cardiovasc Pharmacol 2004; 43: 685-691
39. Greco AJ, Master RG, Fokin A Jr et al. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I. Can J Physiol Pharmacol 2006; 84: 1163-1175